Titan Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company is engaged in the development of therapeutics for serious medical disorders using its proprietary long-term drug delivery platform. The company’s lead product candidate is a six-month subdermal buprenorphine implant designed for the maintenance treatment of opioid dependence.